© Copyright 2002-2026, Generis Enterprise Technology Limited, all rights reserved
CARA AI operates natively inside the CARA platform, supporting pharmacovigilance and safety documentation workflows while preserving human review, medical judgment, and controlled processes.
Reduce the manual effort required to assess aggregate reports, signal evaluations, and authority feedback.
Identify where labels, RMPs, and reports diverge as content evolves across versions and regions.
Surface what changed, what’s missing, and what requires attention across ongoing safety activities.
Demonstrate control, traceability, and consistency across safety documentation when regulators ask.
From manual processes to AI-powered efficiency
Compare current and prior PBRERs, PSURs, labels, and RMPs to identify semantic differences and misalignment.
Cross-check safety information to ensure risks, mitigations, and wording remain consistent across documents.
Summarise PBRERs, DSURs, signal assessments, and Health Authority feedback into concise review-ready narratives.
Draft boilerplate sections for aggregate reports and first drafts for RMPs, safety variations, and inspection packs.
Adapt safety communications and RMPs for regional use while enforcing controlled terminology (e.g., MedDRA, ICH, EMA).
“CARA will reduce manual effort, shorten submission cycles…”
“Moving from a system with no versioning … was a real breath of fresh air.”
See CARA AI automate classification, extraction, summarization and generation across R&D, Regulatory, Safety and Quality
© Copyright 2002-2026, Generis Enterprise Technology Limited, all rights reserved